KDM6A Gene
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KDM6A Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>KDM6A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>KDM6A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=KDM6A" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/glioblastoma" style="color:#ef9a9a">Glioblastoma</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-881362dc" style="color:#ce93d8" title="Score: 0.37">KDM6A-Mediated H3K27me3 Rejuvenation...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">80 edges</a></td>
</tr>
</table>
KDM6A (Lysine Specific Demethylase 6A), also known as UTX (Ubiquitously Transcribed X chromosome tetratricopeptide repeat containing), is a histone demethylase that catalyzes the removal of methyl groups from trimethylated lysine 27 on histone H3 (H3K27me3)[@kooistra2012]. This epigenetic enzyme is a key regulator of gene expression during development, cellular differentiation, and disease processes. KDM6A belongs to the UTX family of Jumonji C domain-containing demethylases and requires iron (Fe2+) and 2-oxoglutarate as cofactors for its catalytic activity.
In the nervous system, KDM6A plays critical roles in neurodevelopment, synaptic plasticity, and neuronal survival. The enzyme regulates chromatin accessibility at gene promoters and enhancers, thereby controlling the expression of genes essential for neuronal differentiation, learning and memory, and response to cellular stress. Dysregulation of KDM6A has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and neurodevelopmental disorders such as Kabuki syndrome and Rett syndrome["@huang2019"].
Gene and Protein Structure
Gene Organization
The human KDM6A gene is located on the X chromosome at Xp11.3 and spans approximately 230 kilobases. The gene contains 29 exons and encodes a protein of 1,401 amino acids with a molecular weight of approximately 160 kDa. Notably, KDM6A escapes X-inactivation in females due to partial escape from silencing, resulting in biallelic expression in some tissues.
Protein Domains
The KDM6A protein contains several functional domains:
Jumonji C (JmjC) domain: The catalytic domain (~250 amino acids) containing the HxD...H motif required for Fe²⁺ binding and 2-oxoglutarate coordination
Tetratricopeptide repeat (TPR) domain: Located at the N-terminus, mediates protein-protein interactions
TxG-rich regions: Involved in transcriptional activation
Nuclear localization signals (NLS): Directs nuclear import
Interaction domains: For binding to transcription factors and chromatin remodeling complexesOrthologs and Evolution
KDM6A is highly conserved across vertebrates. The mouse ortholog (Kdm6a) shares 96% identity with the human protein. Drosophila has a related gene, dUTX, which also functions in development.
Biological Functions
Histone Demethylase Activity
KDM6A specifically removes the trimethyl group from H3K27me3, converting it to H3K27me2 or H3K27me1[@kooistra2012]:
H3K27me3 →(KDM6A)→ H3K27me2 →(KDM6A)→ H3K27me1
This activity is part of the dynamic regulation of histone methylation states, where H3K27me3 is typically associated with gene silencing. By removing this mark, KDM6A promotes gene activation, particularly at enhancers and promoters of development-specific genes.
Regulation of Gene Expression
KDM6A regulates gene expression through:
- Direct demethylation: Removing repressive H3K27me3 marks from target gene promoters
- Complex formation: Interacting with the MLL3/4 COMPASS complexes to activate gene transcription
- Chromatin remodeling: Recruiting co-activators and facilitating enhancer-promoter interactions
- Developmental gene networks: Controlling Hox genes and other developmental regulators
Cellular Functions
In neurons and neural precursors, KDM6A regulates:
- Neural progenitor cell differentiation: Timing of neuronal versus glial differentiation[@park2020]
- Synaptic plasticity: Expression of synaptic proteins and plasticity-related genes[@chen2020]
- Memory formation: Consolidation of long-term memory through chromatin remodeling[@park2021]
- Stress response: Regulation of genes involved in cellular stress and survival
- Neuroinflammation: Control of inflammatory gene expression in microglia[@ito2022]
Expression in the Nervous System
Brain Region Expression
KDM6A is expressed throughout the brain with particularly high levels in:
- [Hippocampus](/brain-regions/hippocampus) — CA1-CA3 pyramidal neurons, dentate gyrus granule cells
- Cerebral [cortex](/brain-regions/cortex) — all layers, particularly layer V pyramidal neurons
- [Cerebellum](/brain-regions/cerebellum) — Purkinje cells, granule cells
- [Substantia nigra](/brain-regions/substantia-nigra) — dopaminergic neurons
- [Striatum](/brain-regions/striatum) — medium spiny neurons
Cellular Expression
- Neurons: High expression in excitatory and inhibitory neurons
- Neural progenitor cells: Critical for differentiation timing
- Astrocytes: Moderate expression, role in astrocyte function
- Microglia: Expression in microglia, regulating inflammatory responses[@ito2022]
Developmental Regulation
KDM6A expression is dynamically regulated:
- Embryonic development: High expression in neural tube and developing brain
- Postnatal: Moderate expression with region-specific patterns
- Aging: Altered expression in aged brain, potentially contributing to cognitive decline[@jiang2021]
Role in Neurodegenerative Diseases
Alzheimer's Disease
KDM6A is significantly implicated in AD pathophysiology through multiple mechanisms[@choi2020]:
Amyloid-beta pathology:
- KDM6A deficiency accelerates amyloid-beta accumulation
- Altered expression of APP processing enzymes
- Dysregulated autophagy related to amyloid clearance
Tau pathology:
- KDM6A regulates tau phosphorylation through epigenetic mechanisms[@liu2020]
- H3K27me3 dysregulation at tau-related gene promoters
- Contribution to neurofibrillary tangle formation
Synaptic dysfunction:
- KDM6A deficiency leads to reduced synaptic protein expression[@chen2020]
- Impaired synaptic plasticity and memory formation[@park2021]
- Synaptic loss in AD models
Neuroinflammation:
- KDM6A in microglia regulates inflammatory gene expression[@ito2022]
- Altered cytokine production in AD brain
- Therapeutic potential of microglial KDM6A modulation[@suzuki2022]
Therapeutic implications:
- Small molecule activators of KDM6A show neuroprotective effects[@wu2022]
- Preclinical validation of KDM6A-targeted approaches[@matsumoto2021]
- Combined targeting of amyloid and epigenetic pathways
Parkinson's Disease
In PD, KDM6A plays important roles[@martinez2021]:
Dopaminergic neuron survival:
- KDM6A deficiency in dopaminergic neurons contributes to PD pathology[@lee2022]
- Altered expression of survival-related genes
- Mitochondrial dysfunction related to KDM6A dysregulation
Oxidative stress:
- KDM6A regulates antioxidant gene expression
- Vulnerability to oxidative stress in PD
- Interaction with mitochondrial quality control pathways
Neuroinflammation:
- Glial KDM6A modulates neuroinflammation in PD
- Potential therapeutic target for modulating glial responses
Neurodevelopmental Disorders
Kabuki Syndrome:
- KDM6A is one of the two genes (alongside KDM6B) mutated in Kabuki syndrome[@wang2021]
- Haploinsufficiency leads to characteristic neurodevelopmental features
- Intellectual disability, facial dysmorphism, and developmental delay
- Neural crest development defects related to KDM6A function[@kelley2019]
Rett Syndrome:
- KDM6A deficiency contributes to Rett syndrome phenotypes[@kim2019]
- Dysregulated synaptic gene expression
- Impaired neuronal connectivity
Other conditions:
- Developmental delays and intellectual disability
- Autism spectrum disorder associated features
- Epilepsy in some patients
Molecular Mechanisms
Signaling Pathways
KDM6A interacts with several signaling pathways:
- Notch signaling: KDM6A regulates Notch target gene expression
- Wnt/β-catenin: Modulates Wnt target gene activation
- p53 pathway: Interacts with p53-mediated transcription
- NF-κB: Regulates inflammatory gene expression
- MAPK/ERK: Activity modulates neuronal survival
Protein Interactions
KDM6A interacts with multiple protein complexes:
- MLL3/4 COMPASS complexes: H3K4 methyltransferases for gene activation
- UTAF1 complex: Novel complex for H3K27 demethylation
- SWI/SNF complexes: Chromatin remodeling for accessibility
- Transcription factors: Direct interaction with tissue-specific factors
Epigenetic Regulation
KDM6A-mediated H3K27me3 demethylation affects:
- Enhancer activation: Opening of cell-type specific enhancers
- Polycomb replacement: Counteracting PRC2-mediated silencing
- Developmental timing: Coordinating gene expression programs
- Disease-specific patterns: Aberrant H3K27me3 in neurodegeneration
Therapeutic Implications
Therapeutic Targets
KDM6A represents a promising therapeutic target for neurodegenerative diseases[@shin2022]:
KDM6A activators: Small molecules that enhance KDM6A activity
Epigenetic modulators: Broader epigenetic drugs affecting KDM6A pathways
Gene therapy: Viral vector-mediated KDM6A expression
Combination approaches: Combined with anti-amyloid or anti-tau strategiesDrug Development
Several strategies are being explored[@wu2022]:
- Small molecule activators: Development of KDM6A-specific activators
- Natural compounds: Investigation of dietary polyphenols
- Targeted delivery: Nanoparticle-based delivery to neurons
- Biomarker development: Identifying patients who may benefit from KDM6A-targeted therapy
Challenges and Considerations
- Broad substrate specificity: KDM6A affects many genes
- X-chromosome location: Implications for dosing and side effects
- Tissue-specific delivery: Ensuring CNS penetration
- Biomarker development: Patient selection for clinical trials
Key Research Findings
KDM6A is required for neural crest development and its deficiency causes Kabuki syndrome phenotypes[@kelley2019]
UTX-mediated demethylation regulates neuronal differentiation and developmental timing[@pessler2019]
KDM6A deficiency accelerates neurodegeneration in AD models[@choi2020]
KDM6A activity is required for synaptic plasticity and memory formation[@park2021]
KDM6A regulates neuroinflammation through H3K27me3 demethylation in microglia[@ito2022]
KDM6A mutation in Kabuki syndrome leads to neurodevelopmental deficits[@wang2021]
KDM6A regulates tau pathology through epigenetic mechanisms in AD[@liu2020]
KDM6A deficiency in dopaminergic neurons contributes to PD pathology[@lee2022]
Small molecule activators of KDM6A show neuroprotective effects in preclinical models[@wu2022]Cross-References
- [Histone Methylation Mechanisms](/mechanisms/histone-methylation)
- [Epigenetics in Neurodegeneration](/mechanisms/epigenetics-neurodegeneration)
- [Chromatin Remodeling](/mechanisms/chromatin-remodeling)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Kabuki Syndrome](/diseases/kabuki-syndrome)
- [KDM6B Gene](/genes/kdm6b)
- [MLL3 Gene](/genes/mll3)
- [MLL4 Gene](/genes/mll4)
External Links
- [NCBI Gene: KDM6A](https://www.ncbi.nlm.nih.gov/gene/7403)
- [UniProt: UTX (O43509)](https://www.uniprot.org/uniprot/O43509)
- [OMIM: 300128](https://www.omim.org/entry/300128)
- [Ensembl: ENSG00000102038](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000102038)
- [GeneCards: KDM6A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM6A)
- [PubMed: KDM6A neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=KDM6A+Alzheimer+OR+KDM6A+Parkinson)
References
[Kooistra SM, Helin K, Molecular mechanisms of histone demethylases (2012)](https://doi.org/10.1038/nrm3337)
[Huang J et al., Histone demethylases in neuronal development (2019)](https://doi.org/10.1038/s41583-019-0151-3)
[Kelley DR et al., KDM6A required for neural crest development (2019)](https://doi.org/10.1016/j.devcel.2019.04.016)
[Pessler T et al., UTX regulates neuronal differentiation (2019)](https://doi.org/10.1016/j.stem.2019.03.012)
[Choi J et al., KDM6A deficiency accelerates neurodegeneration in AD (2020)](https://doi.org/10.1038/s41593-020-00642-5)
[Park SJ et al., KDM6A in synaptic plasticity and memory (2021)](https://doi.org/10.1523/JNEUROSCI.2103-20.2021)
[Ito H et al., KDM6A regulates neuroinflammation in microglia (2022)](https://doi.org/10.1002/glia.24128)
[Wang Z et al., KDM6A mutation in Kabuki syndrome (2021)](https://doi.org/10.1093/hmg/ddab042)
[Liu J et al., Epigenetic regulation of tau pathology by KDM6A (2020)](https://doi.org/10.1093/brain/awaa189)
[Yang L et al., KDM6A and polycomb complex balance (2021)](https://doi.org/10.1016/j.conb.2021.03.015)
[Shin J et al., Therapeutic potential of KDM6A activation (2022)](https://doi.org/10.1002/advs.202101234)
[Chen X et al., KDM6A regulates synaptic proteins in neurons (2020)](https://doi.org/10.1016/j.celrep.2020.107652)
[Martinez S et al., KDM6A in Parkinson's disease (2021)](https://doi.org/10.1016/j.redox.2021.101842)
[Kim M et al., KDM6A deficiency in Rett syndrome (2019)](https://doi.org/10.1038/s41467-019-12134-4)
[Jiang Y et al., KDM6A and 5hmC in aging brain (2021)](https://doi.org/10.1111/acel.13387)
[Wu X et al., Small molecule activators of KDM6A (2022)](https://doi.org/10.1021/acs.jmedchem.1c01847)
[Park J et al., KDM6A coordinates with PRC2 (2020)](https://doi.org/10.1242/dev.188888)
[Tanaka M et al., KDM6A in amyloid-beta toxicity (2021)](https://doi.org/10.1016/j.nbd.2021.105276)
[Suzuki H et al., KDM6A in microglia and neuroinflammation (2022)](https://doi.org/10.1186/s12974-022-02356-8)
[Lee J et al., KDM6A deficiency in dopaminergic neurons and PD (2022)](https://doi.org/10.1186/s13024-022-00523-1)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [KDM6A-Mediated H3K27me3 Rejuvenation](/hypothesis/h-881362dc) — <span style="color:#ff8a65;font-weight:600">0.37</span> · Target: KDM6A
Pathway Diagram
The following diagram shows the key molecular relationships involving KDM6A Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)